Neng Nana

Precision Genetics: A Breakthrough in Treating the Root Cause of Dravet Syndrome precision-genetics-a-breakthrough-in-treating-the-root-cause-of-dravet-syndrome

Precision Genetics: A Breakthrough in Treating the Root Cause of Dravet Syndrome

Neng Nana May 14, 2026

In a landmark development for the field of genetic medicine, researchers have successfully utilized base editing technology...

A Historic Triumph: Tunisia Eradicates Trachoma as a Public Health Threat a-historic-triumph-tunisia-eradicates-trachoma-as-a-public-health-threat

A Historic Triumph: Tunisia Eradicates Trachoma as a Public Health Threat

Neng Nana May 14, 2026

In a landmark announcement that marks a watershed moment for global health, the World Health Organization (WHO)...

Groundbreaking Study Unveils Direct Link Between Omega-6 Fatty Acid and Aggressive Breast Cancer Growth groundbreaking-study-unveils-direct-link-between-omega-6-fatty-acid-and-aggressive-breast-cancer-growth

Groundbreaking Study Unveils Direct Link Between Omega-6 Fatty Acid and Aggressive Breast Cancer Growth

Neng Nana May 14, 2026

New York, NY – March 14, 2024 – A pivotal preclinical study spearheaded by investigators at Weill...

Lumryz Demonstrates Significant Efficacy in Treating Idiopathic Hypersomnia, Alkermes Reports Promising Phase III Data lumryz-demonstrates-significant-efficacy-in-treating-idiopathic-hypersomnia-alkermes-reports-promising-phase-iii-data

Lumryz Demonstrates Significant Efficacy in Treating Idiopathic Hypersomnia, Alkermes Reports Promising Phase III Data

Neng Nana May 14, 2026

Boston, MA – [Insert Date] – Alkermes plc today announced encouraging top-line results from its pivotal Phase...

J&J Bolsters Cardiovascular Portfolio with Global Launch of Next-Generation Shockwave C2 Aero jj-bolsters-cardiovascular-portfolio-with-global-launch-of-next-generation-shockwave-c2-aero

J&J Bolsters Cardiovascular Portfolio with Global Launch of Next-Generation Shockwave C2 Aero

Neng Nana May 13, 2026

In a significant move to consolidate its leadership in the cardiovascular medical device market, Johnson & Johnson...

From Bedside to Bench: How the ML4H Initiative is Rewriting the Future of Medicine with AI from-bedside-to-bench-how-the-ml4h-initiative-is-rewriting-the-future-of-medicine-with-ai

From Bedside to Bench: How the ML4H Initiative is Rewriting the Future of Medicine with AI

Neng Nana May 12, 2026

The integration of artificial intelligence (AI) into the clinical workflow has long been a promise of the...

Decoding the Stafne Bone Cavity: New Insights into a Century-Old Radiological Enigma decoding-the-stafne-bone-cavity-new-insights-into-a-century-old-radiological-enigma

Decoding the Stafne Bone Cavity: New Insights into a Century-Old Radiological Enigma

Neng Nana May 11, 2026

Since its first description by Edward Stafne in 1942, the Stafne Bone Cavity (SBC)—a distinct, asymptomatic, radiolucent...

The Architecture of Care: Ainat Koller’s Journey Through Breast Cancer and the Power of Communal Support the-architecture-of-care-ainat-kollers-journey-through-breast-cancer-and-the-power-of-communal-support

The Architecture of Care: Ainat Koller’s Journey Through Breast Cancer and the Power of Communal Support

Neng Nana May 11, 2026

NEW YORK — On August 31, 2025, Ainat Koller marked a grueling milestone: the completion of 20...

A New Dawn in Neuro-Oncology: Nottingham Scientists Pioneer Ultra-Rapid Brain Tumour Diagnosis, Cutting Weeks to Hours a-new-dawn-in-neuro-oncology-nottingham-scientists-pioneer-ultra-rapid-brain-tumour-diagnosis-cutting-weeks-to-hours

A New Dawn in Neuro-Oncology: Nottingham Scientists Pioneer Ultra-Rapid Brain Tumour Diagnosis, Cutting Weeks to Hours

Neng Nana May 10, 2026

NOTTINGHAM, UK – In a groundbreaking development set to revolutionise neuro-oncology, scientists and clinicians at the University...

The New Pharma Hegemony: Beyond Keytruda and the Rise of the GLP-1 Era the-new-pharma-hegemony-beyond-keytruda-and-the-rise-of-the-glp-1-era

The New Pharma Hegemony: Beyond Keytruda and the Rise of the GLP-1 Era

Neng Nana May 10, 2026

The pharmaceutical industry has reached a historic inflection point. For years, the oncology juggernaut Keytruda (pembrolizumab) has...

Precision Genetics: A Breakthrough in Treating the Root Cause of Dravet Syndrome

A Historic Triumph: Tunisia Eradicates Trachoma as a Public Health Threat

Groundbreaking Study Unveils Direct Link Between Omega-6 Fatty Acid and Aggressive Breast Cancer Growth

Lumryz Demonstrates Significant Efficacy in Treating Idiopathic Hypersomnia, Alkermes Reports Promising Phase III Data

J&J Bolsters Cardiovascular Portfolio with Global Launch of Next-Generation Shockwave C2 Aero

From Bedside to Bench: How the ML4H Initiative is Rewriting the Future of Medicine with AI

Decoding the Stafne Bone Cavity: New Insights into a Century-Old Radiological Enigma

The Architecture of Care: Ainat Koller’s Journey Through Breast Cancer and the Power of Communal Support

A New Dawn in Neuro-Oncology: Nottingham Scientists Pioneer Ultra-Rapid Brain Tumour Diagnosis, Cutting Weeks to Hours

The New Pharma Hegemony: Beyond Keytruda and the Rise of the GLP-1 Era

You may have missed

The Economics of Access: How Medicaid Reimbursement Shapes the Post-Dobbs Abortion Landscape

Protecting the Pipeline: METAvivor Challenges Proposed Revisions to Federal Research Funding

The Genomic Revolution: Cultivating the Future of the Peanut Industry

Unlocking Glioblastoma’s Secrets: Rogue DNA Rings Offer Hope for Earlier Diagnosis and Smarter Treatments